Figure 3.
Disease-free (a) and breast cancer-specific survival (b–e) of stage I–III patients according to GATA4 status. The solid line shows GATA4-positive cases and the dashed line shows GATA4-negative cases. (a, b) Total cases (n = 140); (c) cases negative for lymph node metastasis (n = 89); (d) estrogen receptor (ER)-positive cases that received adjuvant endocrine therapy following surgery (n = 81); and (e) cases that received adjuvant chemotherapy after surgery (n = 95). Statistical analysis was performed using the log-rank test. P-values < 0.05 were considered significant and are shown in bold.